An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care

Author： Skrepnek Grant H.   Armstrong Edward P.   Malone Daniel C.   Ramachandran Sulabha  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.21, Iss.2, 2005-02, pp. : 261-270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Severity of illness assessment in community-acquired pneumonia

By Challen Kirsty   Bentley Andrew   Walter Darren   Bright John  

Intensive Care Medicine, Vol. 34, Iss. 5, 2008-05 ,pp. : 967-967

Springer Publishing Company

Access to resources Recommend Favorite

Community-acquired pneumonia

By Wyndham Mike  

Community Practitioner, Vol. 79, Iss. 4, 2006-04 ,pp. : 113-113

Community Practitioner

Access to resources Recommend Favorite

Determining best outcomes from community‐acquired pneumonia and how to achieve them

By  

RESPIROLOGY (ELECTRONIC), Vol. 23, Iss. 2, 2018-02 ,pp. : 138-147

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines

By Simoens Steven  

Current Medical Research and Opinion, Vol. 25, Iss. 10, 2009-10 ,pp. : 2447-2457

Informa Healthcare

Access to resources Recommend Favorite

Antibiotic treatment for children hospitalized with community‐acquired pneumonia after oral therapy

By  

PEDIATRIC PULMONOLOGY, Vol. 50, Iss. 5, 2015-05 ,pp. : 495-502

John Wiley & Sons Inc

Access to resources Recommend Favorite